Medicare Enrolled

Dr. William Bartek, M.D

Pulmonary Disease · Austin, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
5920 W WILLIAM CANNON DR, Austin, TX 78749
5124419799
In practice since 2006 (19 years)
NPI: 1598722522 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bartek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bartek? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bartek

Dr. William Bartek is a pulmonary disease specialist in Austin, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bartek performed 1,960 Medicare services across 1,494 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bartek received a total of $277,496 from 28 pharmaceutical and/or device companies across 434 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bartek is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 20% volume in TX $277,496 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,960
Medicare services
Top 20% in TX for pulmonary disease
1,494
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~103 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
325 $96 $270
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
227 $42 $109
Airflow rate measurement test
A test that measures the rate of airflow. This procedure assesses how quickly air moves.
223 $31 $100
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
222 $43 $140
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
219 $68 $183
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
191 $59 $262
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
107 $89 $415
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
106 $167 $1,518
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
79 $124 $393
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
60 $124 $639
Remote patient monitoring management, 20 min/month
Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month.
27 $39 $102
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
24 $102 $747
Computer-assisted navigation of lung airways
This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation.
21 $74 $1,250
Endoscopic needle biopsy of windpipe, airway, or lung
A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung.
21 $113 $523
Bronchoscopy with ultrasound and growth treatment
A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found.
20 $51 $175
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
20 $27 $70
Lung biopsy via endoscope, 1 lobe
A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination.
19 $33 $486
Bronchoscopy
A procedure to examine the airways inside the lungs using a thin, flexible tube with a camera.
18 $0 $375
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
18 $30 $156
Bronchoscopy with ultrasound and lymph node sampling
A procedure using a scope and ultrasound to examine the airways and collect tissue samples from three or more lymph nodes.
13 $181 $955
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$277,496
Total received (2018-2024)
Avg $39,642/year across 7 years
Top 2% in TX for pulmonary disease
28
Companies
434
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$273,507 (98.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,989 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$45,584
2023
$77,408
2022
$106,448
2021
$45,176
2020
$978
2019
$1,326
2018
$577

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$229,407
INTUITIVE SURGICAL, INC.
$45,170
Ethicon Inc.
$1,033
Boehringer Ingelheim Pharmaceuticals, Inc.
$452
GlaxoSmithKline, LLC.
$190
Sunovion Pharmaceuticals Inc.
$167
AstraZeneca Pharmaceuticals LP
$161
Merck Sharp & Dohme Corporation
$135
Insmed, Inc.
$124
United Therapeutics Corporation
$96
Covidien LP
$92
Electromed, Inc.
$72
Mallinckrodt Hospital Products Inc.
$50
Advanced Respiratory, Inc
$48
Mylan Specialty L.P.
$28
Inogen, Inc.
$27
Vifor Pharma, Inc.
$26
Takeda Pharmaceuticals U.S.A., Inc.
$25
Philips Electronics North America Corporation
$25
ANI Pharmaceuticals, Inc.
$22
Mallinckrodt LLC
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Actelion Pharmaceuticals US, Inc.
$19
Allergan Inc.
$19
Olympus America Inc.
$19
Inspire Medical Systems, Inc.
$18
EKOS Corporation
$16
Novartis Pharmaceuticals Corporation
$15
Top 3 companies account for 99.3% of total payments
Associated products mentioned in payments ›
ACTHAR · ANORO · AREXVY · AVYCAZ · Adempas · Arikayce · BRIDION · DA VINCI SP · Da Vinci Surgical System · EKOSONIC · FASENRA · GLASSIA · HIGH DEFINITION LCD MONITOR · INOGEN · INSPIRE · LONHALA MAGNAIR · Life 2000 Ventilation System · MONARCH · Monarch Platform · NUCALA · OFEV · PURIFIED CORTROPHIN GEL · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SuperDimension · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · UPTRAVI · Utibron · Veltassa · Wellcentive Undiv · XOLAIR · YUPELRI · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (99%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for pulmonary disease in TX.

Equivalent to $14,158 per 100 Medicare services performed
Looking for a pulmonary disease specialist in Austin?
Compare pulmonary diseases in the Austin area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
27
Per 100K population
2.1
County median income
$97,169
Nearest hospital
AUSTIN OAKS HOSPITAL
3.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Bartek is a clinical cardiology specialist, with above-average Medicare volume (top 20% in TX), with speaking/promotional industry engagement in the top 2% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Bartek experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bartek performed 325 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bartek receive payments from pharmaceutical companies?
Yes. Dr. Bartek received a total of $277,496 from 28 companies across 434 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bartek's costs compare to other pulmonary diseases in Austin?
Dr. Bartek's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bartek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →